GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, nine have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $98.75.

A number of analysts recently weighed in on the stock. Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. CoreFirst Bank & Trust bought a new position in GE HealthCare Technologies in the 4th quarter worth about $25,000. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies in the 4th quarter worth about $28,000. LGT Financial Advisors LLC grew its position in GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock worth $30,000 after purchasing an additional 123 shares during the last quarter. Accredited Wealth Management LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth about $30,000. Finally, Darwin Wealth Management LLC bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.4 %

Shares of NASDAQ GEHC opened at $82.14 on Wednesday. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.80. The firm has a fifty day moving average of $87.25 and a 200-day moving average of $86.10. The stock has a market capitalization of $37.56 billion, a PE ratio of 18.97, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.